Literature DB >> 19539818

The impact of cognitive behavioral group training on event-free survival in patients with myocardial infarction: the ENRICHD experience.

Patrice G Saab1, Heejung Bang, Redford B Williams, Lynda H Powell, Neil Schneiderman, Carl Thoresen, Matthew Burg, Francis Keefe.   

Abstract

OBJECTIVE: Although the Enhancing Recovery in Coronary Heart Disease (ENRICHD) treatment was designed to include individual therapy and cognitive behavioral group training for patients with depression and/or low perceived social support, only 31% of treated participants received group training. Secondary analyses classified intervention participants into two subgroups, (1) individual therapy only or (2) group training (i.e., coping skills training) plus individual therapy, to determine whether medical outcomes differed in participants who received the combination of group training and individual therapy compared to participants who received individual therapy only or usual care.
METHODS: Secondary analyses of 1243 usual care, 781 individual therapy only, and 356 group plus individual therapy myocardial infarction (MI) patients were performed. Depression was diagnosed using modified Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria; low perceived social support was determined by the ENRICHD Social Support Instrument. Psychosocial treatment followed MI, and for participants with severe or unremitting depression, was supplemented with a selective serotonin reuptake inhibitor. Cox proportional hazards regression was used to estimate intervention effects on time to first occurrence of the composite end point of death plus nonfatal MI. To control for confounding of group participation with survival (because individual sessions preceded group), we used risk set sampling to match minimal survival time of those receiving or not receiving group training.
RESULTS: Analyses correcting for differential survival among comparison groups showed that group plus individual therapy was associated with a 33% reduction (hazard ratio=0.67; 95% confidence interval, 0.49-0.92, P=.01) in medical outcome compared to usual care. No significant effect on event-free survival was associated with individual therapy alone. The group training benefit was reduced to 23% (hazard ratio=0.77; 95% confidence interval: 0.56-1.07, P=.11) in the multivariate-adjusted model.
CONCLUSIONS: Findings suggest that adding group training to individual therapy may be associated with reduction in the composite end point. A randomized controlled trial is warranted to definitively resolve this issue.

Entities:  

Mesh:

Year:  2009        PMID: 19539818      PMCID: PMC2774492          DOI: 10.1016/j.jpsychores.2009.01.015

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  27 in total

1.  Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics.

Authors: 
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

2.  The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity.

Authors:  Kenneth E Freedland; Judith A Skala; Robert M Carney; James M Raczynski; C Barr Taylor; Carlos F Mendes de Leon; Gail Ironson; Marston E Youngblood; K Ranga Rama Krishnan; Richard C Veith
Journal:  Psychosom Med       Date:  2002 Nov-Dec       Impact factor: 4.312

3.  Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. The ENRICHD investigators.

Authors: 
Journal:  Am Heart J       Date:  2000-01       Impact factor: 4.749

4.  Sample-size formula for the proportional-hazards regression model.

Authors:  D A Schoenfeld
Journal:  Biometrics       Date:  1983-06       Impact factor: 2.571

5.  Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design.

Authors: 
Journal:  Psychosom Med       Date:  2001 Sep-Oct       Impact factor: 4.312

6.  Brief group therapy in myocardial infarction rehabilitation: three- to four-year follow-up of a controlled trial.

Authors:  R H Rahe; H W Ward; V Hayes
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

Review 7.  Psychological treatment of cardiac patients: a meta-analysis.

Authors:  Wolfgang Linden; Melanie Jayne Phillips; Jocelyne Leclerc
Journal:  Eur Heart J       Date:  2007-11-05       Impact factor: 29.983

8.  Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial.

Authors:  Neil Schneiderman; Patrice G Saab; Diane J Catellier; Lynda H Powell; Robert F DeBusk; Redford B Williams; Robert M Carney; James M Raczynski; Marie J Cowan; Lisa F Berkman; Peter G Kaufmann
Journal:  Psychosom Med       Date:  2004 Jul-Aug       Impact factor: 4.312

9.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Authors:  Lisa F Berkman; James Blumenthal; Matthew Burg; Robert M Carney; Diane Catellier; Marie J Cowan; Susan M Czajkowski; Robert DeBusk; James Hosking; Allan Jaffe; Peter G Kaufmann; Pamela Mitchell; James Norman; Lynda H Powell; James M Raczynski; Neil Schneiderman
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.

Authors:  S Goldstein
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

View more
  10 in total

Review 1.  Depression in patients with heart disease: the case for more trials.

Authors:  Stanley S Liu; Roy C Ziegelstein
Journal:  Future Cardiol       Date:  2010-07

2.  Myocardial infarction and risk of suicide: another reason to develop and test ways to reduce distress in postmyocardial-infarction patients?

Authors:  Redford B Williams
Journal:  Circulation       Date:  2010-11-22       Impact factor: 29.690

Review 3.  Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective.

Authors:  Flora Ippoliti; Nicoletta Canitano; Rita Businaro
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-18       Impact factor: 4.147

Review 4.  Psychological interventions for coronary heart disease.

Authors:  Suzanne H Richards; Lindsey Anderson; Caroline E Jenkinson; Ben Whalley; Karen Rees; Philippa Davies; Paul Bennett; Zulian Liu; Robert West; David R Thompson; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-04-28

Review 5.  Psychological and pharmacological interventions for depression in patients with coronary artery disease.

Authors:  Phillip J Tully; Ser Yee Ang; Emily Jl Lee; Eileen Bendig; Natalie Bauereiß; Jürgen Bengel; Harald Baumeister
Journal:  Cochrane Database Syst Rev       Date:  2021-12-15

6.  Treating persistent depressive symptoms in post-ACS patients: the project COPES phase-I randomized controlled trial.

Authors:  Matthew M Burg; Francois Lespérance; Nina Rieckmann; Lynn Clemow; Christine Skotzko; Karina W Davidson
Journal:  Contemp Clin Trials       Date:  2007-09-05       Impact factor: 2.226

Review 7.  The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation.

Authors:  Lydia Poole; Chris Dickens; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2011-02-12       Impact factor: 3.006

8.  Effects of psychosocial support interventions on survival in inpatient and outpatient healthcare settings: A meta-analysis of 106 randomized controlled trials.

Authors:  Timothy B Smith; Connor Workman; Caleb Andrews; Bonnie Barton; Matthew Cook; Ryan Layton; Alexandra Morrey; Devin Petersen; Julianne Holt-Lunstad
Journal:  PLoS Med       Date:  2021-05-18       Impact factor: 11.069

9.  Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care.

Authors:  Joseph J Gallo; Knashawn H Morales; Hillary R Bogner; Patrick J Raue; Jarcy Zee; Martha L Bruce; Charles F Reynolds
Journal:  BMJ       Date:  2013-06-05

10.  It's Not the Genes OR the Environment, It's the Genes AND the Environment!

Authors:  Redford B Williams
Journal:  J Am Heart Assoc       Date:  2021-09-02       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.